Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia

por Mancikova, Veronika, Smida, Michal
Publicado 2021

Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia

por Mancikova, Veronika, Peschelova, Helena, Kozlova, Veronika, Ledererova, Aneta, Ladungova, Adriana, Verner, Jan, Loja, Tomas, Folber, Frantisek, Mayer, Jiri, Pospisilova, Sarka, Smida, Michal
Publicado 2020

Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro

por Ledererova, Aneta, Dostalova, Lenka, Kozlova, Veronika, Peschelova, Helena, Ladungova, Adriana, Culen, Martin, Loja, Tomas, Verner, Jan, Pospisilova, Sarka, Smida, Michal, Mancikova, Veronika
Publicado 2021

Integrating Signals from the T-Cell Receptor and the Interleukin-2 Receptor

por Beyer, Tilo, Busse, Mandy, Hristov, Kroum, Gurbiel, Slavyana, Smida, Michal, Haus, Utz-Uwe, Ballerstein, Kathrin, Pfeuffer, Frank, Weismantel, Robert, Schraven, Burkhart, Lindquist, Jonathan A.
Publicado 2011

A chemical genetic screen reveals a resistance mechanism to PI3K inhibitors in cancer

por Muellner, Markus K, Uras, Iris Z, Gapp, Bianca V, Kerzendorfer, Claudia, Smida, Michal, Lechtermann, Hannelore, Craig-Mueller, Nils, Colinge, Jacques, Duernberger, Gerhard, Nijman, Sebastian MB
Publicado 2011

PAG/Cbp suppression reveals a contribution of CTLA-4 to setting the activation threshold in T cells

por Smida, Michal, Cammann, Clemens, Gurbiel, Slavyana, Kerstin, Nadja, Lingel, Holger, Lindquist, Sabine, Simeoni, Luca, Brunner-Weinzierl, Monika C, Suchanek, Miloslav, Schraven, Burkhart, Lindquist, Jonathan A
Publicado 2013

CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells

por Kozlova, Veronika, Ledererova, Aneta, Ladungova, Adriana, Peschelova, Helena, Janovska, Pavlina, Slusarczyk, Aleksander, Domagala, Joanna, Kopcil, Pavel, Vakulova, Viera, Oppelt, Jan, Bryja, Vitezslav, Doubek, Michael, Mayer, Jiri, Pospisilova, Sarka, Smida, Michal
Publicado 2020

Lyn Phosphorylates and Controls ROR1 Surface Dynamics During Chemotaxis of CLL Cells

por Dave, Zankruti, Vondálová Blanářová, Olga, Čada, Štěpán, Janovská, Pavlína, Zezula, Nikodém, Běhal, Martin, Hanáková, Kateřina, Ganji, Sri Ranjani, Krejci, Pavel, Gömöryová, Kristína, Peschelová, Helena, Šmída, Michal, Zdráhal, Zbyněk, Pavlová, Šárka, Kotašková, Jana, Pospíšilová, Šárka, Bryja, Vítězslav
Publicado 2022

A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome

por Skalníková, Magdalena, Staňo Kozubík, Kateřina, Trizuljak, Jakub, Vrzalová, Zuzana, Radová, Lenka, Réblová, Kamila, Holbová, Radka, Kurucová, Terézia, Svozilová, Hana, Štika, Jiří, Blaháková, Ivona, Dvořáčková, Barbara, Prudková, Marie, Stehlíková, Olga, Šmída, Michal, Křen, Leoš, Smejkal, Petr, Pospíšilová, Šárka, Doubek, Michael
Publicado 2022

MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

por Smida, Michal, Fece de la Cruz, Ferran, Kerzendorfer, Claudia, Uras, Iris Z., Mair, Barbara, Mazouzi, Abdelghani, Suchankova, Tereza, Konopka, Tomasz, Katz, Amanda M., Paz, Keren, Nagy-Bojarszky, Katalin, Muellner, Markus K., Bago-Horvath, Zsuzsanna, Haura, Eric B., Loizou, Joanna I., Nijman, Sebastian M. B.
Publicado 2016